- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
AlertFDA Warns of Increased Risk of Death With CLL, Lymphoma Drug -
EHA 2022Venetoclax Combos Improve Progression-Free Survival in CLL
-
AlertFDA Adds RA Indication for Riabni Rituximab Biosimilar
-
AlertFDA Withdraws Lymphoma Drug Approval After Investigation
-
ACMS 2022Post-Mohs Bleeding Risk in Patients on Ibrutinib for CLL Studied
-
'Agony of Choice' for Clinicians Treating Leukemia
-
ED Visits, Readmissions Common After CAR T Therapy
-
FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers
Perspective View All
Journal Articles View All
-
COVID-19 and Immune-Mediated RBC Destruction
-
Safety of IV Golimumab in RA, PsA, and AS
-
Cryotherapy for Cutaneous Kaposi Sarcoma With B-Cell CLL
-
The BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients
-
Malignancy Risk in Patients With Secukinumab-treated Psoriasis
-
SARS-CoV-2 Variants in Patient Given Antibody Monotherapy
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education